Photo from Ramy Sedhom/X
Feb 28, 2024, 19:14
Ramy Sedhom: Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability
Ramy Sedhom, Medical Oncologist and
”This work needs more attention! Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability.
Mentee of Supriya Mohile shows primary dose reduction improves treatment tolerability among older adults with advanced cancer and age-related conditions.”
Read further.
Source: Ramy Sedhom/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19